Exciting updates in R/R multiple myeloma: highlights at ASH 2022 Published 2023-02-21 Download video MP4 360p Recommendations 1:03:49 A 2023 Update on CAR-T Therapy in Myeloma with Dr. Craig Hofmeister 08:07 Multiple myeloma is no longer a dead end: Dr Pravas Mishra 05:29 Updates on Teclistamab, Talquetamab, and CARVYKTI | Mark Wildgust, PHD | ASH 2022 02:18 Efficacy of subsequent therapies for CLL patients treated in the MURANO trial 01:43 Ide-cel therapy for multiple myeloma with renal impairment 05:14 Gravitas | Alaskapox: The new killer virus claims its first victim 44:53 Update in Multiple Myeloma 01:49 The management of Richter's transformation: current approaches and future outlooks 08:11 Improvements over time in elderly patients with AML treated with alloSCT: an EBMT Registry study 02:00 What is CAR T-Cell Therapy? 01:57 What is the Survival Rate for Multiple Myeloma? 59:12 CAR T-cell Therapy: The Good, The Bad and The Long-Term 2022 01:12 Exciting Advances in Myeloma Treatment | Timothy Schmidt, MD | ASCO 2023 00:59 The importance of the EBMT-EHA European CAR T-cell meeting 2024 13:23 This World: Could a new cell therapy method bring a cure for cancer? 31:15 Multiple Myeloma in 2023: What Patients & Caregivers Need to Know Now! | The Patient Story Similar videos 03:42 Prospective evaluation of the biology of aggressive myeloma lesions after induction | ASH 2022 03:54 Highlights in multiple myeloma from ASH 2021: cilta-cel, bispecific antibodies & disease biology 02:29 Myeloma highlights at ASH 2022: BiTEs, CAR-T therapy, novel targets, and more 04:57 ASH 2022: Talquetamab Showing Promise in Multiple Myeloma Clinical Trial 01:43 ASH 2022: What to look forward to in the field of multiple myeloma 10:02 ASH 2022: Talquetamab in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Phase 1/2 Re... 1:15:59 February 25, 2022 | Yale ASH 2021Highlights: Multiple Myeloma 02:10 New Developments at ASH | Rafat Abonour, MD | ASH 2022 04:33 Highlights in multiple myeloma at EHA 2022 03:59 Multiple myeloma highlights from ASH 2020 1:03:39 Top Myeloma Research Presented at ASH 2022 1:02:14 February 10, 2023 | Post ASH CME Series 2022: Multiple Myeloma 1:01:18 Update on Lymphoma from the 2022 American Society of Hematology ASH Annual Meeting | LRF Webinars 59:27 IMWG Conference Series: Reporting from ASH 2022 1:00:50 Best of ASH 2021 Webinar 1:05:39 IMWG Conference Series: ASCO & EHA 2023 08:43 Results from MonumenTAL-1: First-in-Human Study of Talquetamab in Pts with RR Multiple Myeloma 02:41 MonumenTAL-1: talquetamab for multiple myeloma 03:44 ASH 2021: New Bispecific Antibody, Talquetamab, To Treat Multiple Myeloma More results